Abstract
The diagnosis and treatment of tuberculosis in immunocompromised patients is often challenging. Although HIV infection is the greatest risk factor for TB; there are a growing number of cases of TB in patients on immunosuppressive therapy. Here we present two challenging cases of tuberculosis in immunocompromised hosts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158(1):157–61.
Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS. 2007;21(3):335–41.
Centers for Disease Control and Prevention (CDC). TB and HIV Coinfection. 2011. http://www.cdc.gov/tb/topic/TBHIVcoinfection/default.htm. Accessed 12 Feb 2011.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1–166. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
CDC. Managing drug interactions in the treatment of HIV-related tuberculosis. Division of Tuberculosis Elimination (DTBE). 2007. Available at: http://www.cdc.gov/tb/publications/guidelines/TB_HIV_Drugs/PDF/tbhiv.pdf. Accessed 12 Feb 2011.
CDC. Treatment of tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52(RR-11):1–77.
CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMW R Recomm Rep. 2000;49(RR-6):1–51. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm.
Study of latent tuberculosis infection in immunosuppressed rheumatology patients with an interferon-gamma release assay. Am J Respir Crit Care Med. 2008;177:A786.
Furst D, Keystone E, Fleischmann R, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis. 2010;69(Suppl I):2–29. doi:doi:10.1136/ard.2009.123885.
Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection United States. MMRW. 2010;59(RR-5):1–25.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Christianakis, S., Banerjee, J., Kim, J.S., Jones, B.E. (2012). Tuberculosis in Immunocompromised Hosts. In: Mahmoudi, M. (eds) Challenging Cases in Pulmonology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7098-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7098-5_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7097-8
Online ISBN: 978-1-4419-7098-5
eBook Packages: MedicineMedicine (R0)